In this study, we have identified novel ACE2-binding peptoids that block spike-ACE2 interaction and prevent SARS-CoV-2 pseudotyped virus infection without affecting ACE2 expression and its enzymatic activity. The gene discussed is ACE2; the disease is viral infectious disease.